BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 21919432)

  • 1. The Boston Type I keratoprosthesis: an assessment of its efficacy and safety.
    Verdejo-Gómez L; Peláez N; Gris O; Güell JL
    Ophthalmic Surg Lasers Imaging; 2011; 42(6):446-52. PubMed ID: 21919432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
    Greiner MA; Li JY; Mannis MJ
    Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
    Aldave AJ; Kamal KM; Vo RC; Yu F
    Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boston type 1 keratoprosthesis: the university of california davis experience.
    Bradley JC; Hernandez EG; Schwab IR; Mannis MJ
    Cornea; 2009 Apr; 28(3):321-7. PubMed ID: 19387235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
    Pujari S; Siddique SS; Dohlman CH; Chodosh J
    Cornea; 2011 Dec; 30(12):1298-303. PubMed ID: 21963861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
    Sejpal K; Yu F; Aldave AJ
    Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis.
    Li JY; Greiner MA; Brandt JD; Lim MC; Mannis MJ
    Am J Ophthalmol; 2011 Aug; 152(2):209-18. PubMed ID: 21636070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure.
    Kang JJ; de la Cruz J; Cortina MS
    Cornea; 2012 Dec; 31(12):1436-40. PubMed ID: 22367042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Boston keratoprosthesis in Stevens-Johnson syndrome.
    Sayegh RR; Ang LP; Foster CS; Dohlman CH
    Am J Ophthalmol; 2008 Mar; 145(3):438-44. PubMed ID: 18207122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results from the multicenter Boston Type 1 Keratoprosthesis Study.
    Zerbe BL; Belin MW; Ciolino JB;
    Ophthalmology; 2006 Oct; 113(10):1779.e1-7. PubMed ID: 16872678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term visual outcomes of Boston type 1 keratoprosthesis implantation.
    Dunlap K; Chak G; Aquavella JV; Myrowitz E; Utine CA; Akpek E
    Ophthalmology; 2010 Apr; 117(4):687-92. PubMed ID: 20096462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers.
    Robert MC; Biernacki K; Harissi-Dagher M
    Cornea; 2012 Apr; 31(4):339-45. PubMed ID: 22269678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study.
    Akpek EK; Harissi-Dagher M; Petrarca R; Butrus SI; Pineda R; Aquavella JV; Dohlman CH
    Am J Ophthalmol; 2007 Aug; 144(2):227-231. PubMed ID: 17543875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medium-term outcomes of boston type 1 keratoprosthesis implantation in Bangkok, Thailand.
    Lekhanont K; Thaweesit P; Muntham D; Chuckpaiwong V; Vongthongsri A
    Cornea; 2014 Dec; 33(12):1312-9. PubMed ID: 25285588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corneal replacement using a synthetic hydrogel cornea, AlphaCor: device, preliminary outcomes and complications.
    Hicks CR; Crawford GJ; Lou X; Tan DT; Snibson GR; Sutton G; Downie N; Werner L; Chirila TV; Constable IJ
    Eye (Lond); 2003 Apr; 17(3):385-92. PubMed ID: 12724702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Boston keratoprosthesis type I in mucous membrane pemphigoid.
    Palioura S; Kim B; Dohlman CH; Chodosh J
    Cornea; 2013 Jul; 32(7):956-61. PubMed ID: 23538625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boston type 1 keratoprosthesis combined with silicone oil for treatment of hypotony in prephthisical eyes.
    Chan CC; Holland EJ; Sawyer WI; Neff KD; Petersen MR; Riemann CD
    Cornea; 2011 Oct; 30(10):1105-9. PubMed ID: 21642848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International results with the Boston type I keratoprosthesis.
    Aldave AJ; Sangwan VS; Basu S; Basak SK; Hovakimyan A; Gevorgyan O; Kharashi SA; Jindan MA; Tandon R; Mascarenhas J; Malyugin B; Padilla MD; Maskati Q; Agarwala N; Hutauruk J; Sharma M; Yu F
    Ophthalmology; 2012 Aug; 119(8):1530-8. PubMed ID: 22512986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boston keratoprosthesis type I in the elderly.
    Homayounfar G; Grassi CM; Al-Moujahed A; Colby KA; Dohlman CH; Chodosh J
    Br J Ophthalmol; 2017 Apr; 101(4):514-518. PubMed ID: 27381593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative posterior segment complications in eyes treated with the Boston type I keratoprosthesis.
    Goldman DR; Hubschman JP; Aldave AJ; Chiang A; Huang JS; Bourges JL; Schwartz SD
    Retina; 2013 Mar; 33(3):532-41. PubMed ID: 23073339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.